BEPREVE®: a second-generation dual-acting antihistamine with several described mechanisms of action that play a role in the allergic response1†
01
Selective H1 receptor-antagonist
02
Stabilization of mast cell
03
Inhibitory action on eosinophilic migration to inflammatory sites
04
Suppression of vascular permeability
Adapted from Product Monograph1
Adapted from Product Monograph1
BEPREVE® inhibits the production of interleukin-5 (IL-5), a key factor in eosinophil activation, as well as other mediators of inflammatory and allergic reactions such as leukotriene B4 (LTB4), leukotriene D4 (LTD4), platelet activating factor (PAF) and substance P.
BEPREVE® demonstrates activity in both early and late phases of the allergic response
† Clinical significance has not been established.
